NVO Jan 2026 105.000 call
| Previous Close | 42.50 |
| Open | 42.50 |
| Bid | 43.80 |
| Ask | 45.00 |
| Strike | 105.00 |
| Expire Date | 2026-01-16 |
| Day's Range | 42.50 - 42.50 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 262 |
GlobeNewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 3 June 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiate
PR NewswireNovo Nordisk launches national Wegovy® campaign, Power of Wegovy®
Novo Nordisk today launched The Power of Wegovy®, a new national campaign. The campaign aims to educate on the clinical data of Wegovy® (semaglutide) 2.4 mg injection and reflect the collective empowerment people living with obesity can feel when they don't have to manage their weight alone.
ZacksNew to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
